Transients and Migrants

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Register follow-upN/A1 trial
Active Trials
NCT04446949Not Yet Recruiting70,000Est. Feb 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Mission TherapeuticsRegister follow-up

Clinical Trials (1)

Total enrollment: 70,000 patients across 1 trials

NCT04446949Mission TherapeuticsRegister follow-up

Maternal Health Care and Pregnancy Outcomes in Undocumented Migrant Women in Norway.

Start: Jan 2021Est. completion: Feb 202870,000 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space